Medical Devices Brazil

Brazil HPV Testing Market Analysis, 2024–2034

Brazil HPV Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Sample, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Brazil · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $32.0 Mn Estimated value
Estimate 2025 $36.1 Mn 2.2% of the global market
Projected 2034 $108.6 Mn 200.4% Adds $72.4 Mn over 9 forecast years
CAGR 2025–2034 13.0% Faster than 72% of 173 Medical Devices markets here
Key players 5
  • Brazil is 2.22% of the global market.
  • In Latin America, the largest is Brazil (this report) at $36.1 Mn.
  • Fastest growing: Brazil (this report) at 13% a year.
  • Brazil ranks 1st of 3 by size in Latin America.

Market size projection

Brazil

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$72.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
HPV Testing Market market size by year, Brazil
YearMarket sizeChange that yearSince 2025
2024 (estimate) $32.0 Mn — —
2025 (base) $36.1 Mn +$4.2 Mn —
2026 (forecast) $40.8 Mn +$4.7 Mn +13%
2027 (forecast) $46.1 Mn +$5.3 Mn +27.7%
2028 (forecast) $52.1 Mn +$6.0 Mn +44.3%
2029 (forecast) $58.9 Mn +$6.8 Mn +63%
2030 (forecast) $66.6 Mn +$7.7 Mn +84.2%
2031 (forecast) $75.2 Mn +$8.7 Mn +108.2%
2032 (forecast) $85.0 Mn +$9.8 Mn +135.3%
2033 (forecast) $96.1 Mn +$11.1 Mn +165.8%
2034 (forecast) $108.6 Mn +$12.5 Mn +200.4%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.63 Bn
  2. US $698.0 Mn
  3. North America $686.3 Mn
  4. APAC $382.4 Mn
  5. Europe $262.3 Mn
  6. Canada $132.0 Mn
  7. China $130.7 Mn
  8. Japan $102.9 Mn
  9. Latin America $78.1 Mn
  10. Germany $59.2 Mn
  11. Middle East $56.2 Mn
  12. UK $40.9 Mn
  13. France $41.1 Mn
  14. Italy $39.5 Mn
  15. Brazil (this report) $36.1 Mn
  16. Spain $34.4 Mn
  17. Ecuador $34.7 Mn
  18. India $33.5 Mn
  19. Saudi Arabia $29.8 Mn
  20. Mexico $28.1 Mn
  21. Africa $27.4 Mn
  22. Australia $19.5 Mn
  23. Russia $15.8 Mn
  24. New Zealand $14.7 Mn
  25. South Africa $10.7 Mn
  26. UAE $7.5 Mn
  27. Egypt $4.6 Mn
  28. Philippines $3.8 Mn
  29. Hong Kong $2.6 Mn
  30. Malaysia $2.4 Mn
  31. Thailand $2.0 Mn
  32. Singapore $1.8 Mn
  33. Kenya $1.2 Mn

The Brazil HPV Testing Market Analysis Executive Summary

HPV testing detects human papillomavirus types that can cause cervical cancer, used for cervical screening, including self-collected samples.

Key segments of the HPV Testing market include test (HPV DNA Tests, HPV mRNA Tests and Genotyping Tests) and sample (Clinician-Collected and Self-Collected).

Brazil HPV Testing Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the HPV Testing market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the HPV Testing market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the HPV Testing market.

Competitive Landscape for HPV Testing Market in Brazil

The HPV Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for HPV Testing Market in Brazil

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how HPV Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Brazil.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in HPV Testing right now, from free public sources.

Clinical trials

2 active trials in Brazil

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Teal Health, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 1,549 papers since 2021 (worldwide)

  1. Performance of HPV-test screening in young women: Results from a population-based study in Brazil. European journal of obstetrics, gynecology, and reproductive biology, 2026
  2. Esophageal Squamous Papillomas: Human Papillomavirus Association and Natural History. Clinical and translational gastroenterology, 2026
  3. Clinical and sonographic characteristics of gastric-type endocervical adenocarcinoma: a descriptive case series of 13 patients. Frontiers in medicine, 2026
  4. Pelvic HPV-associated squamous cell carcinoma of unknown primary origin: a case report. Frontiers in oncology, 2026
  5. Prevalence and genotype distribution of human papillomavirus infections among women undergoing HPV testing during 2019-2024 in Xi'an, China. BMC infectious diseases, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

HPV Testing in context

Brazil compared

  • Health spending per person: 1,010 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 4 countries we cover in Latin America.[1]
  • Doctors: 2.36 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 2nd highest of the 4 countries we cover in Latin America.[2]
  • People aged 65 and over: 11.5% of people (2025). World: 10.4% of people (2025). Highest of the 4 countries we cover in Latin America.[3]

Questions, answered with public data

How many clinical trials on HPV Testing are running in Brazil?
2 studies are recruiting, active or about to start in Brazil.[4]
How much research is published on HPV Testing?
PubMed lists 1,549 papers added since January 2021 that match this market, worldwide.[5]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Brazil. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about HPV Testing in Brazil? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Women's Health Supplements: A Growing FocusAnaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth… Brain Cancer Diagnosis: Imaging and New BiomarkersAbout 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died… Bioinformatics: Making Sense of Health DataSequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Brazil

See all
Same topic, other categories

Related on women's health and oncology

See the topic